Abstract

Although acupuncture is considered to be effective and safe for Alzheimer's disease (AD) and mild cognitive impairment (MCI), the mechanism underlying its therapeutic effect is still unknown. Most studies clarifying the neuronal pathway produced by acupuncture were still applied to healthy subjects with limited single acupuncture point stimulation, which was inconsistency with clinical practice. Thus, in our present study, we investigate the differences between brain activity changes in AD and MCI patients caused by multi-acupuncture point Siguan (four gates), in order to provide visualized evidence for neuronal specificity of clinical acupuncture. Forty-nine subjects were recruited, including 21 AD patients, 14 MCI patients, and 14 healthy controls (HC). AD and MCI patients were randomly divided into two groups, respectively: real acupuncture point group (14 AD and 8 MCI) and sham acupuncture point group (7 AD and 6 MCI). We adopted a 16-minute, single-block, experimental design for acquiring functional MRI images. We found, in AD and MCI patients, Siguan (four gates) elicited extensive activations and deactivations in cognitive-related areas, visual-related areas, the sensorimotor-related area, basal ganglia, and cerebellum. Compared with HC, AD and MCI patients showed similar activations in cognitive-related brain areas (inferior frontal gyrus, supramarginal gyrus, and rolandic operculum) as well as deactivations in cognitive-related areas, visual-related areas, basal ganglia, and cerebellum, which were not found in HC. Compared with sham acupuncture points, real acupuncture points produced more specific brain changes with both activated and deactivated brain activities in AD and MCI. The preliminary results in our study verified the objective evidence for neuronal specificity of acupuncture in AD and MCI patients.

Highlights

  • Alzheimer’s disease (AD) is the most prevalent cause of neurodegenerative diseases characterized by progressive cognitive impairment and aging risk factor [1]

  • We found that real acupuncture point Siguan produced specific activations in extensive cortical and subcortical brain areas, whereas sham points only activated brain regions that were not related to specific needling locations [8]

  • It showed that no significant difference had been found in age and years of education among AD patients, Mild cognitive impairment (MCI) patients, and healthy controls (HC) participants (P = 0.68, 0.60, respectively)

Read more

Summary

Introduction

Alzheimer’s disease (AD) is the most prevalent cause of neurodegenerative diseases characterized by progressive cognitive impairment and aging risk factor [1]. Because a dramatic shift in population demographics may occur by 2050, which is that the population older than 65 years will outnumber the population younger than 5 years by twofold to threefold, the incidence of AD, 30 million worldwide, will triple or quadruple . This phenomenon will cause severe societal and economic burden to public health care due to the patients’ cognitive disability and loss of independent function [2]. Drugs approved by the Food and Drug Administration (FDA) for Evidence-Based Complementary and Alternative Medicine

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call